Journal Review 2025: F-18 Fluoroestradiol - Current Applications and Future Directions

Course overview

UAN: 0018-0000-25-064-H01-P RELEASE: 12/05/2025 EXPIRE: 12/05/2026 CREDITS: 1.25 LEARNING OBJECTIVES: 1.Recognize the incidence/prevalence of breast cancer 2.Understand the role of the estrogen receptor in breast cancer 3. Describe the characteristics of F-18 labeled estradiol 4.Recognize key patient preparation and radiotracer administration requirements when using F-18 estradiol 5. Recognize the clinical indications for F-18 FES PET/CT imaging in patients with breast cancer 6. Identify future uses of F-18 FES in patients with breast cancer and other tumor types NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $225 for nuclear pharmacists and $125 for nuclear pharmacy technicians.